Investment into scalability and mass production of biocompatible graphene quantum dots (GQDs) – In collaboration with Graphene Square Inc.

Patent transfer/sharing between the Korean HQ & US office.

First fundraising from global venture capital firms.

Trademark registration for North America.

Increase scope of partnerships through engagement in key organizations (i.e. Michael J. Fox Foundation, NNPDF).

Partnership with the National Institute of Health (NIH) for studies related to Niemann-Pick Disease Type C (NPC).

Further mechanism studies relevant to target indications with local institutions (i.e. USC, UCLA).

Pre-clinical toxicity studies in Seoul, Republic of Korea.

Enter into agreement with major CROs regarding key target indications.

File Investigational New Drug (IND) application with the US FDA for an indication of a new drug category known as nanomedicine.

Initiate clinical trials for major target indications.

File for the fast track approval of NPC clinical trials.

Further fundraising rounds from global venture capital firms.

Increase media presence of a global brand including strengthening relationships with key stakeholders and organizations.

Expand R&D facilities to promote innovation into additional pipelines.

Strategic partnerships with major global pharmaceutical companies.

While we are proud of all that we have been able to accomplish in our short company history, we are completely aware of the value of meaningful collaboration. It is true in life and especially in science that more minds and more diversity in thinking bring about greater innovation and opportunity. It is only through a multidisciplinary approach, combining expertise from researchers in the laboratory, medical doctors in the field, and the input of patients and healthcare professionals who face neurodegenerative diseases day to day, that we can begin to break down and solve this incredibly complex problem.

Now, more than ever, the world is accessible. With our company’s HQ in Seoul, South Korea, and the US branch office, located in Los Angeles, California, we are seeking global collaborative partners in our key target applications but are also open to expanding into further pipelines. If you are interested in collaborating with BIOGRAPHENE to develop innovative approaches to fight against unsolved challenges, please contact us via the website or send us emails directly, and we will be happy to discuss the ways in which we might work together.